BioRestorative Therapies, Inc. (BRTX) Tops Q2 EPS by 5c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
BioRestorative Therapies Inc. (BRTX) PT Raised to $18 at Roth/MKM
August 14, 2024 5:08 AM EDTRoth/MKM analyst Jonathan Aschoff raised the price target on BioRestorative Therapies Inc. (NASDAQ: BRTX) to $18.00 (from $15.00) while maintaining a Buy rating.
The analyst comments "BRTX ended 2Q24 with $14.7M in cash. BRTX is observing encouraging Phase 2 BRTX-100 results, and although still... More
